The degradation of cytokine mRNA by Regnase-1 in cardiomyocytes plays an important role in restraining sterile inflammation in failing hearts and the Regnase-1–mediated pathway might be a therapeutic target to treat patients with heart failure. This evidence concerns the gene ZC3H12A and heart failure.